Unified Medical Language System® (UMLS®)
2012AA International Classification of Diseases, 10th Edition, Clinical Modification Source Information
Counts
| Attribute Name | Description | Count (MRSAT.RRF) |
|---|---|---|
| ORDER_NO | Order number | 79503 |
| EXCLUDES1 | A pure excludes. It means "NOT CODED HERE!" Indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. Used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition. | 5463 |
| EXCLUDES2 | Represents "Not included here". Indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together. | 2017 |
| ALT_SORT_CODE | Alt sort code | 1020 |
| USE_ADDITIONAL | Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/ manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition. | 697 |
| CODE_FIRST | Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition. | 283 |
| CODE_ALSO | Instructs that 2 codes may be required to fully describe a condition but the sequencing of the two codes is discretionary, depending on the severity of the conditions and the reason for the encounter. | 146 |
| NOTE | Note | 82 |
| MTH_EXCLUDES1 | MTH pure excludes. | 19 |
| MTH_EXCLUDES2 | MTH "Not included here". | 5 |
| FROMRSAB | Root source abbreviation for the "from" identifiers of a map set | 3 |
| FROMVSAB | Versioned source abbreviation for the "from" identifiers of a map set | 3 |
| MAPSETRSAB | Root source abbreviation for a map set | 3 |
| MAPSETVERSION | Version of the map set | 3 |
| MAPSETVSAB | Versioned source abbreviation for a map set | 3 |
| MAPSETXRTARGETID | Map set target identifier used for XR mappings. | 3 |
| MTH_MAPFROMCOMPLEXITY | Indicates the complexity of "from" expressions used in a map set | 3 |
| MTH_MAPFROMEXHAUSTIVE | Indicates whether or not the "from" source of a map set is completely mapped | 3 |
| MTH_MAPSETCOMPLEXITY | Indicates the overall complexity of a map set | 3 |
| MTH_MAPTOCOMPLEXITY | Indicates the complexity of "to" expressions in a map set | 3 |
| MTH_MAPTOEXHAUSTIVE | Indicates whether or not the "to" source is completely mapped | 3 |
| SOS | Scope Statement | 3 |
| TORSAB | Root source abbreviation for the "to" identifiers of a map set | 3 |
| TOVSAB | Versioned source abbreviation for the "to" identifiers of a map set | 3 |
| MTH_CODE_FIRST | MTH Code First note. Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. | 2 |
Notes
- Attributes included every discrete piece of information about a concept, an atom, or a relationship that is not part of the basic Metathesaurus concept structure or distributed in one of the relationship files.
- Attribute Names (ATN) are based on source documentation or NLMs understanding of the source.
- Sample attribute values (ATV) are provided for each ATN in the source.
- Sample data highlight examples of ATNs and Attribute Values (ATV) in MRSAT.RRF.
- See Metathesaurus Documentation for a complete list of attribute names.
- See Section 2.5 of the UMLS Reference Manual for more information on attributes in the UMLS Metathesaurus.
Sample Data
ORDER_NO
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C0343312 | A17798960 | L0039616 | S0000259 | SDUI | A33 | ORDER_NO | 00237 | Tetanus neonatorum |
| C0040820 | A17824911 | L0574766 | S0647440 | SDUI | B66.9 | ORDER_NO | 01104 | Fluke infection, unspecified |
| C3263732 | A20151360 | L10356874 | S12918701 | SDUI | C44.112 | ORDER_NO | 01594 | Basal cell carcinoma of skin of right eyelid, including canthus |
| C0496828 | A17850442 | L0748778 | S0940570 | SDUI | C67.2 | ORDER_NO | 01932 | Malignant neoplasm of lateral wall of bladder |
| C2874068 | A17863448 | L9364763 | S11686853 | SDUI | E10.641 | ORDER_NO | 03847 | Type 1 diabetes mellitus with hypoglycemia with coma |
| C0837061 | A17825393 | L1692152 | S11664077 | SDUI | E13.11 | ORDER_NO | 03915 | Other specified diabetes mellitus with ketoacidosis with coma |
| C0268274 | A17812555 | L0393933 | S0890468 | SDUI | E75.0 | ORDER_NO | 04317 | GM2 gangliosidosis |
| C0494368 | A17812604 | L0834681 | S0995523 | SDUI | E89.4 | ORDER_NO | 04485 | Postprocedural ovarian failure |
| C2874577 | A17787039 | L9346442 | S11620288 | SDUI | F14.122 | ORDER_NO | 04764 | Cocaine abuse with intoxication with perceptual disturbance |
| C2874980 | A17863707 | L9348787 | S11639829 | SDUI | F63.9 | ORDER_NO | 05320 | Impulse disorder, unspecified |
| C2875015 | A20106701 | L10385055 | S12917326 | SDUI | G04.00 | ORDER_NO | 05439 | Acute disseminated encephalitis and encephalomyelitis, unspecified |
| C0522253 | A17838445 | L5561706 | S9305464 | SDUI | G44.84 | ORDER_NO | 05788 | Primary exertional headache |
| C3264243 | A20098156 | L10361010 | S12952487 | SDUI | H40.1532 | ORDER_NO | 08422 | Residual stage of open-angle glaucoma, bilateral, moderate stage |
| C0029077 | A17838822 | L0042169 | S0003153 | SDUI | H44.13 | ORDER_NO | 08643 | Sympathetic uveitis |
| C2881492 | A17864286 | L9393787 | S11674134 | SDUI | H59.3 | ORDER_NO | 09290 | Postprocedural hemorrhage and hematoma of eye and adnexa following a procedure |
| C2881629 | A17800453 | L9408579 | S11626993 | SDUI | H61.90 | ORDER_NO | 09489 | Disorder of external ear, unspecified, unspecified ear |
| C0694539 | A20143217 | L1217750 | S7015525 | SDUI | I48.2 | ORDER_NO | 10454 | Chronic atrial fibrillation |
| C2882755 | A17839179 | L9407184 | S11614912 | SDUI | I70.318 | ORDER_NO | 11003 | Atherosclerosis of unspecified type of bypass graft(s) of the extremities with intermittent claudication, other extremity |
| C2977016 | A18908442 | L9594392 | S12053738 | SDUI | I82.5Z2 | ORDER_NO | 11463 | Chronic embolism and thrombosis of unspecified deep veins of left distal lower extremity |
EXCLUDES1
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2887087 | A17773456 | L9361977 | S11663756 | SDUI | A41 | EXCLUDES1 | bacteremia NOS (R78.81) | Other sepsis |
| C0005716 | A17811970 | L0005716 | S0019549 | SDUI | B40 | EXCLUDES1 | Brazilian blastomycosis (B41.-) | Blastomycosis |
| C0153362 | A17812042 | L0847211 | S0940594 | SDUI | C08 | EXCLUDES1 | malignant neoplasms of specified minor salivary glands which are classified according to their anatomical location | Malignant neoplasm of other and unspecified major salivary glands |
| C0153470 | A17824985 | L0180303 | S0244826 | SDUI | C26.1 | EXCLUDES1 | Hodgkin lymphoma (C81.-) | Malignant neoplasm of spleen |
| C0042237 | A17837684 | L0180419 | S0244942 | SDUI | C52 | EXCLUDES1 | carcinoma in situ of vagina (D07.2) | Malignant neoplasm of vagina |
| C0036221 | A17863204 | L0024616 | S0005252 | SDUI | C96.2 | EXCLUDES1 | mast cell leukemia (C94.30) | Malignant mast cell tumor |
| C0154073 | A17837838 | L0180906 | S0245433 | SDUI | D04 | EXCLUDES1 | erythroplasia of Queyrat (penis) NOS (D07.4) | Carcinoma in situ of skin |
| C0496876 | A17837865 | L0180806 | S0970902 | SDUI | D21 | EXCLUDES1 | uterine leiomyoma (D25.-) | Other benign neoplasms of connective and other soft tissue |
| C0011854 | A17786848 | L0011862 | S0750962 | SDUI | E10 | EXCLUDES1 | gestational diabetes (O24.4-) | Type 1 diabetes mellitus |
| C0405581 | A17786896 | L0181052 | S0245580 | SDUI | E29 | EXCLUDES1 | azoospermia or oligospermia NOS (N46.0-N46.1) | Testicular dysfunction |
| C0869496 | A17812505 | L0545292 | S0637199 | SDUI | E34.2 | EXCLUDES1 | ectopic ACTH syndrome (E24.3) | Ectopic hormone secretion, not elsewhere classified |
| C0221468 | A17812518 | L0035580 | S0217849 | SDUI | E55.0 | EXCLUDES1 | renal rickets (N25.0) | Rickets, active |
| C1832200 | A17774145 | L6447539 | S11627095 | SDUI | E71.51 | EXCLUDES1 | Refsum's disease (G60.1) | Disorders of peroxisome biogenesis |
| C0349079 | A17799747 | L0545152 | S0629396 | SDUI | F02 | EXCLUDES1 | dementia with Parkinsonism (G31.83) | Dementia in other diseases classified elsewhere |
| C2874387 | A17863587 | L9406981 | S11613297 | SDUI | F10.22 | EXCLUDES1 | alcohol dependence with withdrawal (F10.23-) | Alcohol dependence with intoxication |
| C0006868 | A17863601 | L0006868 | S0362092 | SDUI | F12.1 | EXCLUDES1 | cannabis dependence (F12.2-) | Cannabis abuse |
| C0024517 | A17812712 | L0024517 | S0217953 | SDUI | F32 | EXCLUDES1 | bipolar disorder (F31-) | Major depressive disorder, single episode |
| C0003431 | A17799888 | L0003431 | S0356087 | SDUI | F60.2 | EXCLUDES1 | conduct disorders (F91.-) | Antisocial personality disorder |
| C0349329 | A17825656 | L0542408 | S0703300 | SDUI | F84.3 | EXCLUDES1 | Asperger's syndrome (F84.5) | Other childhood disintegrative disorder |
EXCLUDES2
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C0348161 | A17862803 | L0538510 | S0703584 | SDUI | A74 | EXCLUDES2 | chlamydial pneumonia (J16.0) | Other diseases caused by chlamydiae |
| C0751098 | A17799032 | L0026583 | S0217650 | SDUI | A83 | EXCLUDES2 | Venezuelan equine encephalitis (A92.2) | Mosquito-borne viral encephalitis |
| C0016085 | A17812011 | L0016085 | S0041542 | SDUI | B74 | EXCLUDES2 | tropical (pulmonary) eosinophilia NOS (J82) | Filariasis |
| C0348999 | A17862944 | L0583519 | S0668955 | SDUI | B83.4 | EXCLUDES2 | external hirudiniasis (B88.3) | Internal hirudiniasis |
| C0153382 | A17786440 | L0180215 | S0244738 | SDUI | C10 | EXCLUDES2 | malignant neoplasm of tonsil (C09.-) | Malignant neoplasm of oropharynx |
| C2874360 | A17774202 | L9376678 | S11614032 | SDUI | F06.4 | EXCLUDES2 | anxiety disorders, not due to known physiological condition or unspecified (F40.-, F41.-) | Anxiety disorder due to known physiological condition |
| C2874526 | A17838216 | L9363736 | S11678356 | SDUI | F13.2 | EXCLUDES2 | sedative, hypnotic, or anxiolytic poisoning (T42.-) | Sedative, hypnotic or anxiolytic-related dependence |
| C0005586 | A17812705 | L0005586 | S0601096 | SDUI | F31 | EXCLUDES2 | cyclothymia (F34.0) | Bipolar disorder |
| C0236801 | A17838295 | L0861613 | S1031238 | SDUI | F40.2 | EXCLUDES2 | nosophobia (F45.22) | Specific (isolated) phobias |
| C0236795 | A17863683 | L0279852 | S0633509 | SDUI | F44.0 | EXCLUDES2 | postictal amnesia in epilepsy (G40.-) | Dissociative amnesia |
| C0349449 | A17851026 | L0563286 | S0633531 | SDUI | F44.2 | EXCLUDES2 | manic stupor (F30, F31) | Dissociative stupor |
| C0037650 | A17812738 | L0037650 | S0405194 | SDUI | F45 | EXCLUDES2 | hair-plucking (F63.3) | Somatoform disorders |
| C0030662 | A17787141 | L0030662 | S0000196 | SDUI | F63.0 | EXCLUDES2 | gambling in antisocial personality disorder (F60.2) | Pathological gambling |
| C1263846 | A17851058 | L0004269 | S11615002 | SDUI | F90 | EXCLUDES2 | mood [affective] disorders (F30-F39) | Attention-deficit hyperactivity disorders |
| C0149654 | A17812774 | L0159429 | S0844483 | SDUI | F91 | EXCLUDES2 | conduct problems associated with attention-deficit hyperactivity disorder (F90.-) | Conduct disorders |
| C1527281 | A17851062 | L0372274 | S0510692 | SDUI | F93.0 | EXCLUDES2 | phobic anxiety disorder of childhood (F40.8) | Separation anxiety disorder of childhood |
| C0014058 | A17863742 | L0014058 | S0638376 | SDUI | G04 | EXCLUDES2 | alcoholic encephalopathy (G31.2) | Encephalitis, myelitis and encephalomyelitis |
| C0004138 | A17774360 | L0004138 | S0489039 | SDUI | G11 | EXCLUDES2 | cerebral palsy (G80.-) | Hereditary ataxia |
| C0917799 | A17863817 | L0020524 | S0050497 | SDUI | G47.1 | EXCLUDES2 | primary hypersomnia (F51.11) | Hypersomnia |
ALT_SORT_CODE
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2883788 | A17873195 | L9373319 | S11672180 | SDUI | T50.993 | ALT_SORT_CODE | T50.Z96 | Poisoning by other drugs, medicaments and biological substances, assault |
| C2842059 | A18921476 | L9370367 | S11648216 | SDUI | C4A.31 | ALT_SORT_CODE | C43.9 | Merkel cell carcinoma of nose |
| C2842073 | A18916215 | L9380681 | S11648211 | SDUI | C4A.72 | ALT_SORT_CODE | C43.9 | Merkel cell carcinoma of left lower limb, including hip |
| C2349321 | A18916226 | L7963125 | S9305043 | SDUI | C7A.023 | ALT_SORT_CODE | C75.9 | Malignant carcinoid tumor of the transverse colon |
| C2349329 | A18910991 | L7962511 | S9305037 | SDUI | C7A.095 | ALT_SORT_CODE | C75.9 | Malignant carcinoid tumor of the midgut NOS |
| C2845977 | A18913630 | L9382403 | S11662112 | SDUI | C7A.8 | ALT_SORT_CODE | C75.9 | Other malignant neuroendocrine tumors |
| C2977947 | A18913631 | L9594780 | S12057271 | SDUI | C7B-C7B | ALT_SORT_CODE | C75.9 | Secondary neuroendocrine tumors (C7B) |
| C2854008 | A18918912 | L9357332 | S11625618 | SDUI | C84.A6 | ALT_SORT_CODE | C84.79 | Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes |
| C2854013 | A18918913 | L9361800 | S11662138 | SDUI | C84.Z0 | ALT_SORT_CODE | C84.79 | Other mature T/NK-cell lymphomas, unspecified site |
| C2854019 | A18916234 | L9341289 | S11662131 | SDUI | C84.Z6 | ALT_SORT_CODE | C84.79 | Other mature T/NK-cell lymphomas, intrapelvic lymph nodes |
| C2854021 | A18918915 | L9392362 | S11662136 | SDUI | C84.Z8 | ALT_SORT_CODE | C84.79 | Other mature T/NK-cell lymphomas, lymph nodes of multiple sites |
| C2854114 | A18911005 | L9400801 | S11647965 | SDUI | C91.A | ALT_SORT_CODE | C91.62 | Mature B-cell leukemia Burkitt-type |
| C2861608 | A18921494 | L9335435 | S11612070 | SDUI | C92.A0 | ALT_SORT_CODE | C92.62 | Acute myeloid leukemia with multilineage dysplasia, not having achieved remission |
| C0334663 | A18924152 | L3085265 | S3351879 | SDUI | C96.A | ALT_SORT_CODE | C96.6 | Histiocytic sarcoma |
| C2349349 | A18913655 | L7962608 | S9305851 | SDUI | D3A.02 | ALT_SORT_CODE | D36.9 | Benign carcinoid tumors of the appendix, large intestine, and rectum |
| C2349358 | A18924161 | L7963212 | S9305850 | SDUI | D3A.09 | ALT_SORT_CODE | D36.9 | Benign carcinoid tumors of other sites |
| C2349358 | A18916261 | L7963212 | S9305850 | SDUI | D3A.098 | ALT_SORT_CODE | D36.9 | Benign carcinoid tumors of other sites |
| C2873720 | A18916263 | L9392706 | S11665130 | SDUI | D47.Z | ALT_SORT_CODE | D47.4 | Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue |
| C2887135 | A18908443 | L9337988 | S11634246 | SDUI | I82.A | ALT_SORT_CODE | I82.729 | Embolism and thrombosis of axillary vein |
USE_ADDITIONAL
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2900465 | A17773528 | L9365922 | S11696296 | SDUI | A92.39 | USE_ADDITIONAL | code to specify the other conditions | West Nile virus infection with other complications |
| C0004997 | A17812315 | L0004997 | S0217785 | SDUI | D27 | USE_ADDITIONAL | code to identify any functional activity. | Benign neoplasm of ovary |
| C0019068 | A17863388 | L0019068 | S3649637 | SDUI | D76.2 | USE_ADDITIONAL | code to identify infectious agent or disease. | Hemophagocytic syndrome, infection-associated |
| C2873880 | A17850773 | L9378071 | S11626080 | SDUI | E08 | USE_ADDITIONAL | code to identify any insulin use (Z79.4) | Diabetes mellitus due to underlying condition |
| C2874013 | A17799601 | L9399196 | S11633884 | SDUI | E09.69 | USE_ADDITIONAL | code to identify complication | Drug or chemical induced diabetes mellitus with other specified complication |
| C2874115 | A17786861 | L9375070 | S11686916 | SDUI | E11.621 | USE_ADDITIONAL | code to identify site of ulcer (L97.4-, L97.5-) | Type 2 diabetes mellitus with foot ulcer |
| C2874131 | A17774090 | L9413112 | S11664058 | SDUI | E13.22 | USE_ADDITIONAL | code to identify stage of chronic kidney disease (N18.1-N18.6) | Other specified diabetes mellitus with diabetic chronic kidney disease |
| C2875005 | A17825666 | L9348163 | S11634302 | SDUI | F98.1 | USE_ADDITIONAL | code to identify the cause of any coexisting constipation. | Encopresis not due to a substance or known physiological condition |
| C0494447 | A17787177 | L0664537 | S0918704 | SDUI | G06 | USE_ADDITIONAL | code (B95-B97) to identify infectious agent. | Intracranial and intraspinal abscess and granuloma |
| C1510449 | A17864079 | L0008690 | S0003111 | SDUI | H20.1 | USE_ADDITIONAL | code for any associated cataract (H26.21-) | Chronic iridocyclitis |
| C0271008 | A17813256 | L0181639 | S0246178 | SDUI | H44.6 | USE_ADDITIONAL | code to identify magnetic foreign body (Z18.11) | Retained (old) intraocular foreign body, magnetic |
| C2882049 | A17800562 | L9341278 | S11662009 | SDUI | H95.88 | USE_ADDITIONAL | code , if applicable, to further specify disorder | Other intraoperative complications and disorders of the ear and mastoid process, not elsewhere classified |
| C2882050 | A17775037 | L9361936 | S11663327 | SDUI | H95.89 | USE_ADDITIONAL | code, if applicable, to further specify disorder | Other postprocedural complications and disorders of the ear and mastoid process, not elsewhere classified |
| C2882085 | A17864426 | L9359012 | S11639452 | SDUI | I13.11 | USE_ADDITIONAL | code to identify the stage of chronic kidney disease (N18.5, N18.6) | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
| C2882517 | A17826416 | L9372293 | S11663760 | SDUI | I69.198 | USE_ADDITIONAL | code to identify the sequelae | Other sequelae of nontraumatic intracerebral hemorrhage |
| C2882560 | A17813553 | L9337963 | S11634071 | SDUI | I69.291 | USE_ADDITIONAL | code to identify the type of dysphagia, if known (R13.1-) | Dysphagia following other nontraumatic intracranial hemorrhage |
| C2882558 | A17775168 | L9341496 | S11663763 | SDUI | I69.298 | USE_ADDITIONAL | code to identify the sequelae | Other sequelae of other nontraumatic intracranial hemorrhage |
| C2882640 | A17839164 | L9361979 | S11663762 | SDUI | I69.898 | USE_ADDITIONAL | code to identify the sequelae | Other sequelae of other cerebrovascular disease |
| C2882902 | A17826460 | L9386894 | S11614784 | SDUI | I70.56 | USE_ADDITIONAL | code to identify the severity of any ulcer (L98.49-), if applicable | Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene |
CODE_FIRST
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C0475534 | A17863345 | L0699401 | S0804072 | SDUI | D63.0 | CODE_FIRST | neoplasm (C00-D49) | Anemia in neoplastic disease |
| C0475532 | A17850710 | L0699400 | S1023788 | SDUI | D64.1 | CODE_FIRST | underlying disease | Secondary sideroblastic anemia due to disease |
| C0011269 | A17774195 | L0011269 | S1058534 | SDUI | F01 | CODE_FIRST | the underlying physiological condition or sequelae of cerebrovascular disease. | Vascular dementia |
| C2874348 | A17863581 | L9351501 | S11662480 | SDUI | F06 | CODE_FIRST | the underlying physiological condition | Other mental disorders due to known physiological condition |
| C2874369 | A17774204 | L9365458 | S11692559 | SDUI | F09 | CODE_FIRST | the underlying physiological condition | Unspecified mental disorder due to known physiological condition |
| C0694469 | A17812782 | L1217560 | S1458475 | SDUI | G01 | CODE_FIRST | underlying disease | Meningitis in bacterial diseases classified elsewhere |
| C0477345 | A17787182 | L0777490 | S1024924 | SDUI | G09 | CODE_FIRST | condition resulting from (sequela) of inflammatory diseases of central nervous system | Sequelae of inflammatory diseases of central nervous system |
| C0477363 | A17787192 | L0784912 | S0877013 | SDUI | G26 | CODE_FIRST | underlying disease | Extrapyramidal and movement disorders in diseases classified elsewhere |
| C0694474 | A17787242 | L1217565 | S1458480 | SDUI | G46 | CODE_FIRST | underlying cerebrovascular disease (I60-I69) | Vascular syndromes of brain in cerebrovascular diseases |
| C1561868 | A17838456 | L5540621 | S6341422 | SDUI | G47.37 | CODE_FIRST | underlying condition | Central sleep apnea in conditions classified elsewhere |
| C0694479 | A17787309 | L1217570 | S1458485 | SDUI | G94 | CODE_FIRST | underlying disease | Other disorders of brain in diseases classified elsewhere |
| C0271170 | A17838738 | L0393103 | S11638381 | SDUI | H26.23 | CODE_FIRST | underlying glaucoma (H40-H42) | Glaucomatous flecks (subcapsular) |
| C0694494 | A17800522 | L1217586 | S1458501 | SDUI | H75 | CODE_FIRST | underlying disease | Other disorders of middle ear and mastoid in diseases classified elsewhere |
| C1955779 | A17813460 | L6710691 | S7808860 | SDUI | I25.82 | CODE_FIRST | coronary atherosclerosis (I25.1-, I25.7-, I25.81-) | Chronic total occlusion of coronary artery |
| C2882220 | A17864456 | L9374039 | S11678482 | SDUI | I26.90 | CODE_FIRST | underlying infection | Septic pulmonary embolism without acute cor pulmonale |
| C0007177 | A17787860 | L0007177 | S0362334 | SDUI | I31.4 | CODE_FIRST | underlying cause | Cardiac tamponade |
| C2882264 | A17851805 | L9407658 | S11619134 | SDUI | I46.8 | CODE_FIRST | underlying condition | Cardiac arrest due to other underlying condition |
| C0348653 | A17813646 | L0511440 | S0591572 | SDUI | I79.1 | CODE_FIRST | underlying disease | Aortitis in diseases classified elsewhere |
| C2887263 | A17839274 | L9343264 | S11678212 | SDUI | I85.1 | CODE_FIRST | underlying disease | Secondary esophageal varices |
CODE_ALSO
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2845975 | A18921487 | L9390610 | S11647226 | SDUI | C7A | CODE_ALSO | any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-) | Malignant neuroendocrine tumors |
| C0346416 | A18924158 | L0524674 | S11615382 | SDUI | D3A | CODE_ALSO | any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-) | Benign neuroendocrine tumors |
| C2873810 | A17825311 | L9335551 | S11613229 | SDUI | D70.1 | CODE_ALSO | underlying neoplasm | Agranulocytosis secondary to cancer chemotherapy |
| C1955745 | A17838086 | L6708187 | S11649544 | SDUI | E31.2 | CODE_ALSO | any associated malignancies and other conditions associated with the syndromes | Multiple endocrine neoplasia [MEN] syndromes |
| C1260388 | A17774144 | L2688534 | S3162300 | SDUI | E71.42 | CODE_ALSO | associated inborn error or metabolism | Carnitine deficiency due to inborn errors of metabolism |
| C0019202 | A17863557 | L0043180 | S0413588 | SDUI | E83.01 | CODE_ALSO | associated Kayser Fleischer ring (H18.04-) | Wilson's disease |
| C2874962 | A17863693 | L9400094 | S11641854 | SDUI | F51.05 | CODE_ALSO | associated mental disorder | Insomnia due to other mental disorder |
| C2874993 | A17838352 | L9363814 | S11679053 | SDUI | F80.4 | CODE_ALSO | type of hearing loss (H90.-, H91.-) | Speech and language development delay due to hearing loss |
| C0477339 | A17799910 | L0825645 | S0971968 | SDUI | G04.8 | CODE_ALSO | any associated seizure (G40.-, R56.9) | Other encephalitis, myelitis and encephalomyelitis |
| C0154723 | A17863790 | L0374288 | S0497268 | SDUI | G43.1 | CODE_ALSO | any associated seizure (G40.-, R56.9) | Migraine with aura |
| C2875252 | A17812857 | L9338857 | S11641853 | SDUI | G47.01 | CODE_ALSO | associated medical condition | Insomnia due to medical condition |
| C0037315 | A17812859 | L0037314 | S0001660 | SDUI | G47.3 | CODE_ALSO | any associated underlying condition | Sleep apnea |
| C2875863 | A17825879 | L9347104 | S11625859 | SDUI | H05.32 | CODE_ALSO | associated bone disease | Deformity of orbit due to bone disease |
| C2880343 | A17838679 | L9367409 | S11623234 | SDUI | H18.03 | CODE_ALSO | associated metabolic disorder | Corneal deposits in metabolic disorders |
| C0494531 | A17838782 | L0738195 | S0815591 | SDUI | H35.0 | CODE_ALSO | any associated hypertension (I10-) | Background retinopathy and retinal vascular changes |
| C0494532 | A17864186 | L0832631 | S0892844 | SDUI | H40.3 | CODE_ALSO | underlying condition | Glaucoma secondary to eye trauma |
| C0494533 | A17774769 | L0832630 | S0892843 | SDUI | H40.4 | CODE_ALSO | underlying condition | Glaucoma secondary to eye inflammation |
| C0494534 | A17813233 | L0815638 | S0892845 | SDUI | H40.5 | CODE_ALSO | underlying eye disorder | Glaucoma secondary to other eye disorders |
| C0155312 | A17774820 | L0182172 | S0246736 | SDUI | H47.5 | CODE_ALSO | underlying condition | Disorders of other visual pathways |
NOTE
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C0037354 | A17824847 | L0037354 | S0086408 | SDUI | B03 | NOTE | In 1980 the 33rd World Health Assembly declared that smallpox had been eradicated.<br>The classification is maintained for surveillance purposes. | Smallpox |
| C0348296 | A18910973 | L9595323 | S12057280 | SDUI | B90-B94 | NOTE | Categories B90-B94 are to be used to indicate conditions in categories A00-B89 as the cause of sequelae, which are themselves classified elsewhere. The 'sequelae' include conditions specified as such; they also include residuals of diseases classifiable to the above categories if there is evidence that the disease itself is no longer present. Codes from these categories are not to be used for chronic infections. Code chronic current infections to active infectious disease as appropriate. | Sequelae of infectious and parasitic diseases (B90-B94) |
| C2833793 | A18908307 | L9596532 | S12053396 | SDUI | B95-B97 | NOTE | These categories are provided for use as supplementary or additional codes to identify the infectious agent(s) in diseases classified elsewhere. | Bacterial and viral infectious agents (B95-B97) |
| C2854012 | A18905766 | L9382410 | S11662139 | SDUI | C84.Z | NOTE | If T-cell lineage or involvement is mentioned in conjunction with a specific lymphoma, code to the more specific description. | Other mature T/NK-cell lymphomas |
| C0348396 | A17863151 | L0736815 | S11687950 | SDUI | C85.1 | NOTE | If B-cell lineage or involvement is mentioned in conjunction with a specific lymphoma, code to the more specific description. | Unspecified B-cell lymphoma |
| C0023449 | A17825126 | L0492251 | S11612020 | SDUI | C91.0 | NOTE | Code C91.0 should only be used for T-cell and B-cell precursor leukemia | Acute lymphoblastic leukemia [ALL] |
| C2118792 | A17786733 | L7013307 | S11649921 | SDUI | D49 | NOTE | Category D49 classifies by site neoplasms of unspecified morphology and behavior. The term 'mass', unless otherwise stated, is not to be regarded as a neoplastic growth. | Neoplasms of unspecified behavior |
| C2976854 | A18921516 | L9595565 | S12054461 | SDUI | E00-E89 | NOTE | All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere. | Endocrine, nutritional and metabolic diseases (E00-E89) |
| C0024586 | A17786901 | L0007094 | S0000456 | SDUI | E34.0 | NOTE | May be used as an additional code to identify functional activity associated with a carcinoid tumor. | Carcinoid syndrome |
| C0348952 | A17863504 | L0557758 | S0734277 | SDUI | E64 | NOTE | This category is to be used to indicate conditions in categories E43, E44, E46, E50-E63 as the cause of sequelae, which are themselves classified elsewhere. The 'sequelae' include conditions specified as such; they also include the late effects of diseases classifiable to the above categories if the disease itself is no longer present | Sequelae of malnutrition and other nutritional deficiencies |
| C2874362 | A18924177 | L9595661 | S12055357 | SDUI | F01-F09 | NOTE | This block comprises a range of mental disorders grouped together on the basis of their having in common a demonstrable etiology in cerebral disease, brain injury, or other insult leading to cerebral dysfunction. The dysfunction may be primary, as in diseases, injuries, and insults that affect the brain directly and selectively; or secondary, as in systemic diseases and disorders that attack the brain only as one of the multiple organs or systems of the body that are involved. | Mental disorders due to known physiological conditions (F01-F09) |
| C0349350 | A18908397 | L9596533 | S12053404 | SDUI | F90-F98 | NOTE | Codes within categories F90-F98 may be used regardless of the age of a patient. These disorders generally have onset within the childhood or adolescent years, but may continue throughout life or not be diagnosed until adulthood | Behavioral and emotional disorders with onset usually occurring in childhood and adolescence (F90-F98) |
| C0477345 | A17787182 | L0777490 | S1024924 | SDUI | G09 | NOTE | Category G09 is to be used to indicate conditions whose primary classification is to G00-G08 as the cause of sequelae, themselves classifiable elsewhere. The 'sequelae' include conditions specified as residuals. | Sequelae of inflammatory diseases of central nervous system |
| C1719410 | A17825705 | L6083816 | S6982420 | SDUI | G40 | NOTE | the following terms are to be considered equivalent to intractable: pharmacoresistant (pharmacologically resistant), treatment resistant, refractory (medically) and poorly controlled | Epilepsy and recurrent seizures |
| C0149931 | A17787211 | L0026089 | S0062541 | SDUI | G43 | NOTE | the following terms are to be considered equivalent to intractable: pharmacoresistant (pharmacologically resistant), treatment resistant, refractory (medically) and poorly controlled | Migraine |
| C0375206 | A17863858 | L0582600 | S0659615 | SDUI | G81 | NOTE | This category is to be used only when hemiplegia (complete)(incomplete) is reported without further specification, or is stated to be old or longstanding but of unspecified cause. The category is also for use in multiple coding to identify these types of hemiplegia resulting from any cause. | Hemiplegia and hemiparesis |
| C2875338 | A17838504 | L9351980 | S11666509 | SDUI | G82 | NOTE | This category is to be used only when the listed conditions are reported without further specification, or are stated to be old or longstanding but of unspecified cause. The category is also for use in multiple coding to identify these conditions resulting from any cause | Paraplegia (paraparesis) and quadriplegia (quadriparesis) |
| C0154700 | A17787291 | L0181544 | S0246081 | SDUI | G83 | NOTE | This category is to be used only when the listed conditions are reported without further specification, or are stated to be old or longstanding but of unspecified cause. The category is also for use in multiple coding to identify these conditions resulting from any cause. | Other paralytic syndromes |
| C1314803 | A18911062 | L9594434 | S12054165 | SDUI | H00-H59 | NOTE | Use an external cause code following the code for the eye condition, if applicable, to identify the cause of the eye condition | Diseases of the eye and adnexa (H00-H59) |
MTH_EXCLUDES1
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C2853883 | A17786573 | L9394296 | S11678858 | SDUI | C83.0 | MTH_EXCLUDES1 | Waldenstrom macroglobulinemia (C88.0) | Small cell B-cell lymphoma |
| C0154300 | A17825304 | L0181139 | S0245668 | SDUI | D69 | MTH_EXCLUDES1 | Waldenstrom hypergammaglobulinemic purpura (D89.0) | Purpura and other hemorrhagic conditions |
| C0017377 | A17812410 | L0017377 | S0217926 | SDUI | D72.0 | MTH_EXCLUDES1 | Chediak (-Steinbrinck)-Higashi syndrome (E70.330) | Genetic anomalies of leukocytes |
| C0014457 | A17837973 | L0014457 | S0038218 | SDUI | D72.1 | MTH_EXCLUDES1 | Loffler's syndrome (J82) | Eosinophilia |
| C2873825 | A17812425 | L9392590 | S11664112 | SDUI | D76 | MTH_EXCLUDES1 | Hand-Schuller-Christian disease (C96.5) | Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue |
| C0010690 | A17838125 | L0010690 | S0029584 | SDUI | E72.04 | MTH_EXCLUDES1 | Fanconi (-de Toni) (-Debre) syndrome without cystinosis (E72.09) | Cystinosis |
| C0494359 | A17863568 | L0784994 | S0861022 | SDUI | E88.0 | MTH_EXCLUDES1 | Waldenstrom macroglobulinemia (C88.0) | Disorders of plasma-protein metabolism, not elsewhere classified |
| C2875322 | A17863856 | L9370556 | S11649682 | SDUI | G73.7 | MTH_EXCLUDES1 | sicca syndrome [Sjogren] (M35.03) | Myopathy in diseases classified elsewhere |
| C0155082 | A17838668 | L0181941 | S7328684 | SDUI | H16.22 | MTH_EXCLUDES1 | Sjogren's syndrome (M35.01) | Keratoconjunctivitis sicca, not specified as Sjgren's |
| C0348723 | A17826693 | L0561818 | S0703602 | SDUI | K11.8 | MTH_EXCLUDES1 | sicca syndrome [Sjogren] (M35.0-) | Other diseases of salivary glands |
| C0023760 | A17813855 | L0023760 | S0218396 | SDUI | K13.0 | MTH_EXCLUDES1 | Perleche due to candidiasis (B37.83) | Diseases of lips |
| C0023760 | A17813855 | L0023760 | S0218396 | SDUI | K13.0 | MTH_EXCLUDES1 | Perleche due to riboflavin deficiency (E53.0) | Diseases of lips |
| C0494887 | A17788499 | L0785077 | S1058611 | SDUI | L95 | MTH_EXCLUDES1 | Henoch(-Schonlein) purpura (D69.0) | Vasculitis limited to skin, not elsewhere classified |
| C2888961 | A17852470 | L9403948 | S11674066 | SDUI | M02 | MTH_EXCLUDES1 | Behcet's disease (M35.2) | Postinfective and reactive arthropathies |
| C2888961 | A17852470 | L9403948 | S11674066 | SDUI | M02 | MTH_EXCLUDES1 | tabetic arthropathy [Charcot's] (A52.16) | Postinfective and reactive arthropathies |
| C0003892 | A18911170 | L0007956 | S12053723 | SDUI | M14.6 | MTH_EXCLUDES1 | Charcot's joint in diabetes mellitus (E08-E13 with final characters 610) | Charct's joint |
| C0003892 | A18911170 | L0007956 | S12053723 | SDUI | M14.6 | MTH_EXCLUDES1 | Charcot's joint in tabes dorsalis (A52.16) | Charct's joint |
| C0026848 | A18905968 | L9595534 | S12054192 | SDUI | M60-M63 | MTH_EXCLUDES1 | Sjogren's syndrome (M35.03) | Disorders of muscles (M60-M63) |
| C0478155 | A17841730 | L0820035 | S0864008 | SDUI | R68.2 | MTH_EXCLUDES1 | dry mouth due to sicca syndrome [Sjogren] (M35.0-) | Dry mouth, unspecified |
MTH_EXCLUDES2
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C0178299 | A18919042 | L9594498 | S12054791 | SDUI | L00-L08 | MTH_EXCLUDES2 | Perleche NOS (K13.0) | Infections of the skin and subcutaneous tissue (L00-L08) |
| C0178299 | A18919042 | L9594498 | S12054791 | SDUI | L00-L08 | MTH_EXCLUDES2 | Perleche due to candidiasis (B37.0) | Infections of the skin and subcutaneous tissue (L00-L08) |
| C0178299 | A18919042 | L9594498 | S12054791 | SDUI | L00-L08 | MTH_EXCLUDES2 | Perleche due to riboflavin deficiency (E53.0) | Infections of the skin and subcutaneous tissue (L00-L08) |
| C0038013 | A17776233 | L0038013 | S0000466 | SDUI | M45 | MTH_EXCLUDES2 | Behcet's disease (M35.2) | Ankylosing spondylitis |
| C0474891 | A17777660 | L0795454 | S0845537 | SDUI | Q82.5 | MTH_EXCLUDES2 | Cafe au lait spots (L81.3) | Congenital non-neoplastic nevus |
FROMRSAB
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | FROMRSAB | ICD9CM | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | FROMRSAB | ICD10CM | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | FROMRSAB | ICD10CM | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
FROMVSAB
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | FROMVSAB | ICD9CM_2012 | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | FROMVSAB | ICD10CM_2012 | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | FROMVSAB | ICD10CM_2012 | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
MAPSETRSAB
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | MAPSETRSAB | ICD10CM | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | MAPSETRSAB | ICD10CM | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | MAPSETRSAB | ICD10CM | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
MAPSETVERSION
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | MAPSETVERSION | 2012 | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | MAPSETVERSION | 2012 | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | MAPSETVERSION | 2012 | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
MAPSETVSAB
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | MAPSETVSAB | ICD10CM_2012 | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | MAPSETVSAB | ICD10CM_2012 | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | MAPSETVSAB | ICD10CM_2012 | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
MAPSETXRTARGETID
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | MAPSETXRTARGETID | NoDx | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | MAPSETXRTARGETID | NoDx | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | MAPSETXRTARGETID | NODX | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
MTH_MAPFROMCOMPLEXITY
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | MTH_MAPFROMCOMPLEXITY | SINGLE SDUI | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | MTH_MAPFROMCOMPLEXITY | SINGLE SDUI | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | MTH_MAPFROMCOMPLEXITY | SINGLE SDUI | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
MTH_MAPFROMEXHAUSTIVE
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | MTH_MAPFROMEXHAUSTIVE | Y | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | MTH_MAPFROMEXHAUSTIVE | Y | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | MTH_MAPFROMEXHAUSTIVE | Y | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
MTH_MAPSETCOMPLEXITY
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | MTH_MAPSETCOMPLEXITY | N_TO_N | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | MTH_MAPSETCOMPLEXITY | N_TO_N | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | MTH_MAPSETCOMPLEXITY | N_TO_ONE | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
MTH_MAPTOCOMPLEXITY
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | MTH_MAPTOCOMPLEXITY | SINGLE SDUI | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | MTH_MAPTOCOMPLEXITY | SINGLE SDUI | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | MTH_MAPTOCOMPLEXITY | SINGLE SDUI, MULTIPLE SDUI | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
MTH_MAPTOEXHAUSTIVE
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | MTH_MAPTOEXHAUSTIVE | N | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | MTH_MAPTOEXHAUSTIVE | N | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | MTH_MAPTOEXHAUSTIVE | N | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
SOS
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | SOS | This set maps ICD-9-CM codes to ICD-10-CM. These are "General Equivalence Mappings" (GEMs) and are rule-based. | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | SOS | This set maps ICD-10-CM codes to ICD-9-CM. These are "General Equivalence Mappings" (GEMs) and are rule-based. | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | SOS | This set maps ICD-10-CM codes to ICD-9-CM for reimbursement purposes. | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
TORSAB
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | TORSAB | ICD10CM | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | TORSAB | ICD9CM | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | TORSAB | ICD9CM | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
TOVSAB
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C3264358 | A20115218 | L10352870 | S12931429 | CODE | MTHU000001 | TOVSAB | ICD10CM_2012 | ICD9CM_2012 to ICD10CM_2012 Mappings (GEMs) |
| C3264359 | A20106096 | L10352870 | S12931426 | CODE | MTHU000002 | TOVSAB | ICD9CM_2012 | ICD10CM_2012 to ICD9CM_2012 Mappings (GEMs) |
| C3264360 | A20106097 | L10369710 | S12931427 | CODE | MTHU000003 | TOVSAB | ICD9CM_2012 | ICD10CM_2012 to ICD9CM_2012 Mappings (Reimbursement) |
MTH_CODE_FIRST
(return to top)| CUI | METAUI | LUI | SUI | STYPE | CODE | ATN | ATV | STR |
|---|---|---|---|---|---|---|---|---|
| C0477595 | A17801746 | L0725380 | S0808834 | SDUI | M36.4 | MTH_CODE_FIRST | underlying disease, such as: Henoch (-Schonlein) purpura (D69.0); serum sickness (T80.6-) | Arthropathy in hypersensitivity reactions classified elsewhere |
| C0156340 | A17840948 | L0183216 | S0247806 | SDUI | N77.0 | MTH_CODE_FIRST | underlying disease, such as: Behcet's disease (M35.2) | Ulceration of vulva in diseases classified elsewhere |
